A call for the appropriate application of clinical pharmacological principles in the search for safe and efficacious COVID-19 (SARS-COV-2) treatments

Emma H Baker^{1

2}, Danijela Gnjidic^{3

4}, Carl M J Kirkpatrick^{4

5}, Munir Pirmohamed^{2

6}, Daniel F B Wright^{4

7}, Anna Y Zecharia²

Affiliations

¹ St George's, University of London, London, UK.
² British Pharmacological Society, London, UK.
³ School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
⁴ Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Hamilton, Australia.
⁵ Centre for Medicine Use and Safety, Monash University, Parkville, Australia.
⁶ MRC Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
⁷ School of Pharmacy, University of Otago, Dunedin, New Zealand.

Free article

Editorial

Emma H Baker et al. Br J Clin Pharmacol. 2021 Mar.

Free article

. 2021 Mar;87(3):707-711.

doi: 10.1111/bcp.14416. Epub 2020 Jun 19.

Emma H Baker^{1

2}, Danijela Gnjidic^{3

4}, Carl M J Kirkpatrick^{4

5}, Munir Pirmohamed^{2

6}, Daniel F B Wright^{4

7}, Anna Y Zecharia²

¹ St George's, University of London, London, UK.
² British Pharmacological Society, London, UK.
³ School of Pharmacy, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
⁴ Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, Hamilton, Australia.
⁵ Centre for Medicine Use and Safety, Monash University, Parkville, Australia.
⁶ MRC Centre for Drug Safety Science and Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
⁷ School of Pharmacy, University of Otago, Dunedin, New Zealand.

No abstract available

Publication types